v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues        
Product revenue, net $ 105,751 $ 109,085 $ 201,307 $ 214,735
Collaboration revenue 560 892 4,615 1,729
Total revenues 106,311 109,977 205,922 216,464
Expenses        
Cost of product revenue (48,162) (43,003) (86,477) (81,455)
Cost of collaboration revenue 0 (217) (20) (412)
Research and development (61,766) (50,614) (127,357) (111,343)
Selling, general, and administrative (72,872) (71,038) (137,942) (134,460)
Loss from operations (76,489) (54,895) (145,874) (111,206)
Interest income 5,879 8,843 12,326 17,449
Interest expenses (1,587) (1,262) (3,224) (2,449)
Foreign currency gains 15,065 2,837 29,902 3,488
Other income, net 5,285 3,750 5,447 3,553
Loss before income tax (51,847) (40,727) (101,423) (89,165)
Income tax benefit (expense) 1,022 0 (418) 0
Net loss $ (50,825) $ (40,727) $ (101,841) $ (89,165)
Loss per share - basic (in dollars per share) $ (0.05) $ (0.04) $ (0.09) $ (0.08)
Loss per share - diluted (in dollars per share) $ (0.05) $ (0.04) $ (0.09) $ (0.08)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares) 1,116,973,380 1,091,933,150 1,112,208,460 1,086,413,130
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares) 1,116,973,380 1,091,933,150 1,112,208,460 1,086,413,130